speb/financial-data huggingface dataset:
Financial ratios for PDD — annual report dated 2025-12-31
Total revenue: 61692244714.28571
Gross profit: 34720565714.28571
Operating income: 13300304428.571428
Net income: 13977505571.428572
Capital expenditures: 163582428.57142857
Operating cash flow: 15276955714.285715
Depreciation & amortization: 428623428.5714286
Net tangible assets: 59052824142.85714
Owner earnings: 14242546571.428572
Return on net tangible assets (%): 24.11831572521212
Capex to operating income (%): 1.22991491999254
Buffett classification: The Great
Stock price: 113.39
P/E ratio: 11.54704779056541
Shares outstanding: 1423396462
Book value: 59055022285.71428
P/B ratio: 2.7330262284097597
Market cap (USD): 161398924826.18
Debt to equity: 0.013011582351060522
Current ratio: 2.4281218697536033
Quick ratio: 2.4281218697536033
Effective tax rate (%): 18.194584360887227
COGS to revenue (%): 43.71972380793323
R&D to revenue (%): 3.8199207502611006
SG&A to revenue (%): 30.901236479334926
Free cash flow (dilution-adjusted): 13979520285.714285
Buyback yield (%): 0
Retained earnings: 40594767000
Receivables turnover: 23.30425087570565
Capitalized R&D asset: 4026819448.4323783
ROCI (R&D-adjusted, %): 21.70078763469795
Rosenberg metric: 1.0683324943720076
FCF margin (%): 22.660093420911185
Revenue growth (%): 14.350459453767566
Rule of 40 score: 37.01055287467875
Financial ratios for PPLPHARMA.NS — annual report dated 2023-03-31
Total revenue: 856566382.4604142
Gross profit: 491136419.0012181
Operating income: -5842874.543239952
Net income: -22711327.649208285
Capital expenditures: 115110840.43848966
Operating cash flow: 58939098.660170525
Depreciation & amortization: 82422655.29841657
Net tangible assets: 283528623.62971985
Owner earnings: -55399512.789281376
Return on net tangible assets (%): -19.539301563298782
Buffett classification: The Gruesome
Stock price: 0.8130328867235079
Shares outstanding: 1326844010
Book value: 825030450.669915
P/B ratio: 1.307549090831918
Market cap (USD): 1078767815.682095
Debt to equity: 0.8322255850003689
Current ratio: 1.258240199841272
Quick ratio: 0.8207309298603974
Interest coverage ratio: -0.14204494980900775
COGS to revenue (%): 42.66218835363695
R&D to revenue (%): 1.2280285136958737
SG&A to revenue (%): 7.8974348765217055
Free cash flow (dilution-adjusted): -58570036.5408039
Buyback yield (%): 0
Inventory turnover: 1.7843663203221185
Receivables turnover: 3.908327497860326
Capitalized R&D asset: 21858428.406511586
ROCI (R&D-adjusted, %): -0.3380977822902835
FCF margin (%): -6.837769697728091
Rule of 40 score: -6.837769697728091
Financial ratios for PPLPHARMA.NS — annual report dated 2024-03-31
Total revenue: 972108166.4468162
Gross profit: 581322700.5636168
Operating income: 55405923.971699245
Net income: 2136946.8761242353
Capital expenditures: 85194867.49010673
Operating cash flow: 120462885.23803814
Depreciation & amortization: 88808010.55282408
Net tangible assets: 434293080.7051205
Owner earnings: 5750089.938841581
Return on net tangible assets (%): 1.3240114094163566
Capex to operating income (%): 153.76490704066836
Buffett classification: The Gruesome
Stock price: 1.5441458733205373
P/E ratio: 958.7700683966186
Shares outstanding: 1326844010
Book value: 948719270.8957909
P/B ratio: 2.1595858389669225
Market cap (USD): 2048840702.5815737
Debt to equity: 0.5953659100762573
Current ratio: 1.2506511340489324
Quick ratio: 0.75265832055478
Effective tax rate (%): 90.06079535947349
Interest coverage ratio: 1.033739791923034
COGS to revenue (%): 40.19979250987798
R&D to revenue (%): 1.2418567528659419
SG&A to revenue (%): 6.992984564067202
Free cash flow (dilution-adjusted): 31781988.24799137
Buyback yield (%): 0
Retained earnings: 116401247.15193668
Inventory turnover: 1.4976745041086823
Receivables turnover: 3.7979273154893813
Capitalized R&D asset: 24704991.114111822
ROCI (R&D-adjusted, %): 4.0620560447968925
Rosenberg metric: 8.573753724262309
FCF margin (%): 3.26938805217106
Revenue growth (%): 13.488946840817881
Rule of 40 score: 16.75833489298894
Financial ratios for PPLPHARMA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 445529144.7682752
Buffett classification: The Gruesome
Stock price: 2.7336359292881034
Shares outstanding: 1326844010
Book value: 944478021.9780219
P/B ratio: 3.840331245295094
Market cap (USD): 3627108458.2967033
Debt to equity: 0.6053252933729768
Current ratio: 1.0275598970465811
Quick ratio: 0.5602540994248967
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PPLPHARMA.NS — quarterly report dated 2024-12-31
Total revenue: 256932043.36169714
Gross profit: 163001515.32812682
Operating income: 16427322.531763608
Net income: 428954.4235924933
Capital expenditures: 0
Depreciation & amortization: 22940902.203053966
Owner earnings: 23369856.62664646
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.1015269844970272
P/E ratio: 2398.41477025
Shares outstanding: 1326844010
Market cap (USD): 4115242501.2332435
Effective tax rate (%): 94.49101796407186
Interest coverage ratio: 1.364146742812893
COGS to revenue (%): 36.5585104935079
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PPLPHARMA.NS — annual report dated 2025-03-31
Total revenue: 1059270516.7173251
Gross profit: 641672901.5665185
Operating income: 79337152.20949262
Net income: 10653495.440729482
Capital expenditures: 77055178.8636895
Operating cash flow: 104313771.33504793
Depreciation & amortization: 95433715.22094926
Net tangible assets: 472125321.4870236
Owner earnings: 29032031.79798925
Return on net tangible assets (%): 6.1492215046947445
Capex to operating income (%): 97.12370146614603
Buffett classification: The Gruesome
Stock price: 2.6210759715252654
P/E ratio: 326.44299440701644
Shares outstanding: 1326844010
Book value: 949902969.3710544
P/B ratio: 3.6611728405017065
Market cap (USD): 3477758952.573229
Debt to equity: 0.5976848108478647
Current ratio: 1.5391859850727643
Quick ratio: 0.9251301685752746
Effective tax rate (%): 78.02189851437392
Interest coverage ratio: 1.6238365276481705
COGS to revenue (%): 39.423132104624216
R&D to revenue (%): 1.0719567376669241
SG&A to revenue (%): 6.682043924511643
Free cash flow (dilution-adjusted): 21033434.650455922
Buyback yield (%): 0
Retained earnings: 122670095.86158521
Inventory turnover: 1.5445712803217018
Receivables turnover: 3.856532398106847
Capitalized R&D asset: 22914519.79095649
ROCI (R&D-adjusted, %): 5.608078878541494
Rosenberg metric: 4.999109229792372
FCF margin (%): 1.9856527977044476
Revenue growth (%): 8.966322193249214
Rule of 40 score: 10.951974990953662
Financial ratios for PPLPHARMA.NS — quarterly report dated 2025-03-31
Total revenue: 321962824.4096329
Gross profit: 210321487.02361467
Operating income: 37202478.37269114
Net income: 17944821.136310495
Capital expenditures: 0
Depreciation & amortization: 28379705.400981996
Net tangible assets: 472125321.4870236
Owner earnings: 46324526.537292495
Return on net tangible assets (%): 9.81191315716493
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.6210759715252654
P/E ratio: 48.450733029823134
Shares outstanding: 1326844010
Book value: 949902969.3710544
P/B ratio: 3.6611728405017065
Market cap (USD): 3477758952.573229
Debt to equity: 0.5976848108478647
Current ratio: 1.5391859850727643
Quick ratio: 0.9251301685752746
Effective tax rate (%): 43.7316715542522
Interest coverage ratio: 3.0693479938271606
COGS to revenue (%): 34.675226119888016
Buyback yield (%): 0
Retained earnings: 122670095.86158521
Inventory turnover: 0.41292861157953903
Receivables turnover: 1.172184105689673
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6716602358092976
Revenue growth (%): 25.31049852602014
Rule of 40 score: 25.31049852602014
Financial ratios for PPLPHARMA.NS — quarterly report dated 2025-06-30
Total revenue: 226270769.9508542
Gross profit: 145057336.76573837
Operating income: -10599110.695062019
Net income: -9560028.083313832
Capital expenditures: 0
Depreciation & amortization: 23084483.969108358
Owner earnings: 13524455.885794526
Buffett classification: The Gruesome
Stock price: 2.378305640065528
P/E ratio: 358.036192987386
Shares outstanding: 1326844010
Market cap (USD): 3155640592.4701614
Interest coverage ratio: -1.0514219384793964
COGS to revenue (%): 35.89214515103092
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -29.721460741389766
Rule of 40 score: -29.721460741389766
Financial ratios for PPLPHARMA.NS — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.155129650507328
P/E ratio: 324.43871067833805
Shares outstanding: 1326844010
Market cap (USD): 2859520867.5490417
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PPLPHARMA.NS — quarterly report dated 2025-12-31
Total revenue: 238372507.5192158
Gross profit: 150780884.48256657
Operating income: -1894842.3749582267
Net income: -15170992.536482122
Capital expenditures: 0
Depreciation & amortization: 23698340.202740338
Owner earnings: 8527347.666258216
Buffett classification: The Gruesome
Stock price: 1.918346886487691
Shares outstanding: 1326844010
Market cap (USD): 2545347075.4383426
Interest coverage ratio: -0.1906095921111609
COGS to revenue (%): 36.745690158747955
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRKS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 64.86
Shares outstanding: 47135528
Market cap (USD): 3057210346.08
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRKS — annual report dated 2022-12-31
Total revenue: 1731237000
Gross profit: 1596020000
Operating income: 507639000
Net income: 291190000
Capital expenditures: 200705000
Operating cash flow: 564588000
Depreciation & amortization: 152620000
Net tangible assets: -660942000
Owner earnings: 243105000
Return on net tangible assets (%): -36.78159354376027
Capex to operating income (%): 39.53695441051613
Buffett classification: The Good
Stock price: 53.51
P/E ratio: 8.66177445406779
Shares outstanding: 47135528
Book value: -437664000
Market cap (USD): 2522222103.2799997
Debt to equity: -5.0948718651751115
Current ratio: 0.5710962204855257
Quick ratio: 0.4362252752892186
Effective tax rate (%): 25.34987040887219
Interest coverage ratio: 4.320295146424286
COGS to revenue (%): 7.810426879739747
SG&A to revenue (%): 11.556707718238462
Free cash flow (dilution-adjusted): 345725000
Buyback yield (%): 27.500472662498066
Retained earnings: 175903000
Inventory turnover: 2.450027178836746
Receivables turnover: 24.36646023926812
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.48669688366941
FCF margin (%): 19.969825044173618
Rule of 40 score: 19.969825044173618
Financial ratios for PRKS — annual report dated 2023-12-31
Total revenue: 1726587000
Gross profit: 1594890000
Operating income: 460571000
Net income: 234196000
Capital expenditures: 304836000
Operating cash flow: 504916000
Depreciation & amortization: 154208000
Net tangible assets: -432265000
Owner earnings: 83568000
Return on net tangible assets (%): -19.332585335384543
Capex to operating income (%): 66.18653801476863
Buffett classification: The Good
Stock price: 52.83
P/E ratio: 10.632845754154639
Shares outstanding: 47135528
Book value: -208216000
Market cap (USD): 2490169944.24
Debt to equity: -10.66821954124563
Current ratio: 0.9495443096504144
Quick ratio: 0.8297239088375942
Effective tax rate (%): 25.202566534762877
Interest coverage ratio: 3.1402710921413277
COGS to revenue (%): 7.6275913116454594
SG&A to revenue (%): 12.813544872051047
Free cash flow (dilution-adjusted): 183048000
Buyback yield (%): 0.7172602834322289
Retained earnings: 410099000
Inventory turnover: 2.674811113819157
Receivables turnover: 23.3812309567337
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.801434061489587
FCF margin (%): 10.60172467416933
Revenue growth (%): -0.2685940746414269
Rule of 40 score: 10.333130599527902
Financial ratios for PRKS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 50.6
Shares outstanding: 47135528
Market cap (USD): 2385057716.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRKS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 56.19
Shares outstanding: 47135528
Market cap (USD): 2648545318.3199997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRKS — annual report dated 2024-12-31
Total revenue: 1725301000
Gross profit: 1593894000
Operating income: 463868000
Net income: 227497000
Capital expenditures: 248430000
Operating cash flow: 480139000
Depreciation & amortization: 163438000
Net tangible assets: -685664000
Owner earnings: 142505000
Return on net tangible assets (%): -20.783503290241285
Capex to operating income (%): 53.5561840868523
Buffett classification: The Good
Stock price: 56.19
P/E ratio: 11.642110965507237
Shares outstanding: 47135528
Book value: -461540000
Market cap (USD): 2648545318.3199997
Debt to equity: -5.1206070979763405
Current ratio: 0.6549986920759178
Quick ratio: 0.5439559374909172
Effective tax rate (%): 21.96339263050294
Interest coverage ratio: 2.7650361822105127
COGS to revenue (%): 7.616468082960597
SG&A to revenue (%): 12.571603447746218
Free cash flow (dilution-adjusted): 218036000
Buyback yield (%): 18.23348072089333
Retained earnings: 637596000
Inventory turnover: 2.866269685468743
Receivables turnover: 21.717743762745148
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.468313656159317
FCF margin (%): 12.637562952783313
Revenue growth (%): -0.07448220101274944
Rule of 40 score: 12.563080751770563
Financial ratios for PRKS — quarterly report dated 2025-03-31
Total revenue: 286949000
Gross profit: 263990000
Operating income: 16888000
Net income: -16133000
Capital expenditures: 56903000
Operating cash flow: 25715000
Depreciation & amortization: 41695000
Net tangible assets: -702409000
Owner earnings: -31341000
Capex to operating income (%): 336.9433917574609
Buffett classification: The Gruesome
Stock price: 45.46
Shares outstanding: 47135528
Book value: -478285000
Market cap (USD): 2142781102.88
Debt to equity: -4.933458084614822
Current ratio: 0.5895582975885187
Quick ratio: 0.4731011166181764
Interest coverage ratio: 0.49514762365496817
COGS to revenue (%): 8.001073361468414
SG&A to revenue (%): 15.381478938766122
Free cash flow (dilution-adjusted): -35398000
Buyback yield (%): 0.21462761613021156
Retained earnings: 621463000
Inventory turnover: 0.4534215463612126
Receivables turnover: 3.5647609819121446
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7906341130904533
FCF margin (%): -12.33599001913232
Rule of 40 score: -12.33599001913232
Financial ratios for PRKS — quarterly report dated 2025-06-30
Total revenue: 490212000
Gross profit: 453039000
Operating income: 140874000
Net income: 80108000
Capital expenditures: 53561000
Operating cash flow: 181196000
Depreciation & amortization: 42974000
Net tangible assets: -618975000
Owner earnings: 69521000
Return on net tangible assets (%): -11.231632941556606
Capex to operating income (%): 38.02050058917899
Buffett classification: The Good
Stock price: 47.15
P/E ratio: 34.73919726768269
Shares outstanding: 47135528
Book value: -394851000
Market cap (USD): 2222440145.2
Debt to equity: -5.966379722984113
Current ratio: 0.8270131183134307
Quick ratio: 0.7164770325927522
Effective tax rate (%): 24.638990018720776
Interest coverage ratio: 4.1493328620659184
COGS to revenue (%): 7.583045702675577
SG&A to revenue (%): 13.137581291359657
Free cash flow (dilution-adjusted): 123749000
Buyback yield (%): 0.206799720115135
Retained earnings: 701571000
Inventory turnover: 0.6967237695393035
Receivables turnover: 5.212636772540221
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.267225260022181
FCF margin (%): 25.243976075657066
Revenue growth (%): 70.83593251762508
Rule of 40 score: 96.07990859328214
Financial ratios for PRKS — quarterly report dated 2025-09-30
Total revenue: 511851000
Gross profit: 471921000
Operating income: 152168000
Net income: 89325000
Capital expenditures: 56763000
Operating cash flow: 94778000
Depreciation & amortization: 44702000
Net tangible assets: -532859000
Owner earnings: 77264000
Return on net tangible assets (%): -14.499895844867028
Capex to operating income (%): 37.30284948215131
Buffett classification: The Good
Stock price: 51.7
P/E ratio: 15.896326142204828
Shares outstanding: 47135528
Book value: -308735000
Market cap (USD): 2436906797.6
Debt to equity: -7.618459196398206
Current ratio: 1.085155977053491
Quick ratio: 0.9461834493904667
Effective tax rate (%): 24.519612648087747
Interest coverage ratio: 4.540295390123825
COGS to revenue (%): 7.801098366516819
SG&A to revenue (%): 11.850518998692978
Free cash flow (dilution-adjusted): 33764000
Buyback yield (%): 0.2917633126963378
Retained earnings: 790896000
Inventory turnover: 0.7662783780153141
Receivables turnover: 6.014558999788489
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.4336915592679444
FCF margin (%): 6.5964509202873485
Revenue growth (%): 4.414212626373895
Rule of 40 score: 11.010663546661243
Financial ratios for PRKS — quarterly report dated 2025-12-31
Total revenue: 373547000
Gross profit: 346046000
Operating income: 56969000
Net income: 15053000
Capital expenditures: 50262000
Operating cash flow: 78396000
Depreciation & amortization: 45103000
Net tangible assets: -659930000
Owner earnings: 9894000
Return on net tangible assets (%): -1.499249920446108
Capex to operating income (%): 88.22693043585107
Buffett classification: The Gruesome
Stock price: 36.3
P/E ratio: 10.163285871947632
Shares outstanding: 47135528
Book value: -435806000
Market cap (USD): 1711019666.3999999
Debt to equity: -5.388344813976861
Current ratio: 0.7350415354064648
Quick ratio: 0.6008494224551116
Effective tax rate (%): 21.15545778336476
Interest coverage ratio: 1.7492860871434275
COGS to revenue (%): 7.362125783368626
SG&A to revenue (%): 15.674868222740379
Free cash flow (dilution-adjusted): 23248000
Buyback yield (%): 8.422346208515794
Retained earnings: 805949000
Inventory turnover: 0.5326760672503292
Receivables turnover: 4.833244918291562
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.552898399402745
FCF margin (%): 6.223580968392197
Revenue growth (%): -27.02036334792742
Rule of 40 score: -20.796782379535223
Financial ratios for PRKS — annual report dated 2025-12-31
Total revenue: 1662559000
Gross profit: 1534996000
Operating income: 366899000
Net income: 168353000
Capital expenditures: 217489000
Operating cash flow: 380085000
Depreciation & amortization: 174474000
Net tangible assets: -659930000
Owner earnings: 125338000
Return on net tangible assets (%): -18.992620429439487
Capex to operating income (%): 59.277621361737154
Buffett classification: The Good
Stock price: 36.3
P/E ratio: 10.163285871947632
Shares outstanding: 47135528
Book value: -435806000
Market cap (USD): 1711019666.3999999
Debt to equity: -5.388344813976861
Current ratio: 0.7350415354064648
Quick ratio: 0.6008494224551116
Effective tax rate (%): 25.684104583357243
Interest coverage ratio: 2.7351945728343523
COGS to revenue (%): 7.67269011205016
SG&A to revenue (%): 13.69870182050682
Free cash flow (dilution-adjusted): 145363000
Buyback yield (%): 9.375286745681324
Retained earnings: 805949000
Inventory turnover: 2.470810412954211
Receivables turnover: 21.511496111894626
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.441500989002222
FCF margin (%): 8.743328808180642
Revenue growth (%): -3.6365828339518727
Rule of 40 score: 5.10674597422877
Financial ratios for PTY — annual report dated 2021-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.33
Shares outstanding: 211981917
Market cap (USD): 2613737036.61
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PTY — annual report dated 2022-06-30
Total revenue: -245518000
Net income: -245939000
Capital expenditures: 0
Operating cash flow: 282438000
Net tangible assets: 1574089000
Owner earnings: -245939000
Return on net tangible assets (%): -15.624211845708851
Buffett classification: The Gruesome
Stock price: 8.12
Shares outstanding: 211981917
Book value: 1574089000
P/B ratio: 1.0935170540166406
Market cap (USD): 1721293166.0399997
Debt to equity: 0.48644199914998454
Free cash flow (dilution-adjusted): 282438000
Buyback yield (%): 0
Retained earnings: -472474000
Receivables turnover: -2.0690009691147346
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PTY — annual report dated 2023-06-30
Total revenue: 135737000
Net income: 135216000
Capital expenditures: 0
Operating cash flow: 428368000
Net tangible assets: 1532891000
Owner earnings: 135216000
Return on net tangible assets (%): 8.8209794434177
Buffett classification: The Gruesome
Stock price: 10.25
P/E ratio: 16.06921258763756
Shares outstanding: 211981917
Book value: 1532891000
P/B ratio: 1.4174619390745982
Market cap (USD): 2172814649.25
Debt to equity: 0.193289672912164
COGS to revenue (%): 0
SG&A to revenue (%): 0.23796017298157468
Free cash flow (dilution-adjusted): 428368000
Buyback yield (%): 0
Retained earnings: -559675000
Receivables turnover: 1.4046796092391753
Capitalized R&D asset: 0
FCF margin (%): 315.5867596896941
Rule of 40 score: 315.5867596896941
Financial ratios for PTY — annual report dated 2024-06-30
Total revenue: 211839000
Net income: 211069000
Capital expenditures: 0
Operating cash flow: 134426000
Net tangible assets: 1821718000
Owner earnings: 211069000
Return on net tangible assets (%): 11.58626088121213
Buffett classification: The Gruesome
Stock price: 11.6
P/E ratio: 11.65017239480928
Shares outstanding: 211981917
Book value: 1821718000
P/B ratio: 1.349819366773562
Market cap (USD): 2458990237.2
Debt to equity: 0.15993144932420936
COGS to revenue (%): 0
SG&A to revenue (%): 0.09818777467793939
Free cash flow (dilution-adjusted): 134426000
Buyback yield (%): 8.197145191984173
Retained earnings: -500918000
Receivables turnover: 4.160150036330787
Capitalized R&D asset: 0
FCF margin (%): 63.45668172527249
Revenue growth (%): 56.065774254624756
Rule of 40 score: 119.52245597989725
Financial ratios for PTY — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 2068967000
Buffett classification: The Gruesome
Stock price: 12.24
Shares outstanding: 211981917
Book value: 2068967000
P/B ratio: 1.2540841222117125
Market cap (USD): 2594658664.08
Debt to equity: 0.1075391729302594
Buyback yield (%): 0
Retained earnings: -452871000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PTY — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 2246776000
Buffett classification: The Gruesome
Stock price: 12.47
Shares outstanding: 211981917
Book value: 2246776000
P/B ratio: 1.1765367375252362
Market cap (USD): 2643414504.9900002
Debt to equity: 0.11458196099655685
Buyback yield (%): 0
Retained earnings: -453557000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PTY — annual report dated 2025-06-30
Total revenue: 275288000
Net income: 274956000
Capital expenditures: 0
Operating cash flow: -108019000
Net tangible assets: 2246776000
Owner earnings: 274956000
Return on net tangible assets (%): 12.237802077287634
Buffett classification: The Gruesome
Stock price: 12.47
P/E ratio: 9.613954614520141
Shares outstanding: 211981917
Book value: 2246776000
P/B ratio: 1.1765367375252362
Market cap (USD): 2643414504.9900002
Debt to equity: 0.11458196099655685
COGS to revenue (%): 0
SG&A to revenue (%): 0.09517305512772078
Free cash flow (dilution-adjusted): -108019000
Buyback yield (%): 0.16550563643126223
Retained earnings: -453557000
Receivables turnover: 3.5193618082100713
Capitalized R&D asset: 0
FCF margin (%): -39.238542907791114
Revenue growth (%): 29.951519786252767
Rule of 40 score: -9.287023121538347
Financial ratios for REVX.V — annual report dated 2021-12-31
Gross profit: -392.1259842519685
Capital expenditures: 0
Depreciation & amortization: 392.1259842519685
Buffett classification: The Gruesome
Stock price: 0.39370078740157477
Shares outstanding: 60069829
Market cap (USD): 23649538.97637795
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for REVX.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -1466.9117647058822
Operating income: -572411.7647058823
Net income: -428689.7058823529
Capital expenditures: 0
Operating cash flow: -421711.76470588235
Depreciation & amortization: 1466.9117647058822
Net tangible assets: 21512.5
Owner earnings: -427222.794117647
Return on net tangible assets (%): -1985.928153946064
Buffett classification: The Gruesome
Stock price: 0.14705882352941177
Shares outstanding: 60069829
Book value: 21512.5
P/B ratio: 410.63560173633664
Market cap (USD): 8833798.38235294
Debt to equity: 0
Current ratio: 1.08344261611392
Quick ratio: 1.08344261611392
Free cash flow (dilution-adjusted): -434594.85294117645
Buyback yield (%): 0
Retained earnings: -29057938.970588233
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2660.8333048501213
Rule of 40 score: 0
Financial ratios for REVX.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: 0
Operating income: -449572.72727272724
Net income: -330262.1212121212
Capital expenditures: 0
Operating cash flow: -54579.54545454545
Depreciation & amortization: 0
Net tangible assets: -165687.12121212122
Owner earnings: -330262.1212121212
Buffett classification: The Gruesome
Stock price: 0.15151515151515152
Shares outstanding: 60069829
Book value: -165687.12121212122
Market cap (USD): 9101489.242424242
Debt to equity: 0
Current ratio: 0.2963177531582952
Quick ratio: 0.2963177531582952
Free cash flow (dilution-adjusted): -58976.515151515145
Buyback yield (%): 0
Retained earnings: -30268744.696969695
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for REVX.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.059259259259259255
Shares outstanding: 60069829
Market cap (USD): 3559693.57037037
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for REVX.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -327545.4545454546
Net income: -767286.0139860141
Capital expenditures: 0
Operating cash flow: -250087.4125874126
Net tangible assets: 743318.8811188812
Owner earnings: -767286.0139860141
Return on net tangible assets (%): -103.22434065324109
Buffett classification: The Gruesome
Stock price: 0.3076923076923077
Shares outstanding: 60069829
Book value: 743318.881118881
P/B ratio: 24.86553856922177
Market cap (USD): 18483024.307692308
Debt to equity: 0
Current ratio: 2.2375597686888256
Quick ratio: 2.2375597686888256
Free cash flow (dilution-adjusted): -297117.48251748254
Buyback yield (%): 0
Retained earnings: -28489976.923076924
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -44.0652676617627
Rule of 40 score: 0
Financial ratios for REVX.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -551612.5874125875
Net income: -549597.2027972029
Capital expenditures: 0
Operating cash flow: -304513.2867132867
Net tangible assets: 743318.8811188812
Owner earnings: -549597.2027972029
Return on net tangible assets (%): -73.93828096629557
Buffett classification: The Gruesome
Stock price: 0.3076923076923077
Shares outstanding: 60069829
Book value: 743318.881118881
P/B ratio: 24.86553856922177
Market cap (USD): 18483024.307692308
Debt to equity: 0
Current ratio: 2.2375597686888256
Quick ratio: 2.2375597686888256
Free cash flow (dilution-adjusted): -351543.3566433566
Buyback yield (%): 0
Retained earnings: -28489976.923076924
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -74.20941421295156
Rule of 40 score: 0
Financial ratios for REVX.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -645279.7202797203
Net income: -645279.7202797203
Capital expenditures: 0
Operating cash flow: -745471.3286713287
Net tangible assets: 489502.7972027972
Owner earnings: -645279.7202797203
Return on net tangible assets (%): -131.82350008357272
Buffett classification: The Gruesome
Stock price: 0.18881118881118883
Shares outstanding: 60069829
Book value: 489502.7972027972
P/B ratio: 23.17015528815453
Market cap (USD): 11341855.825174827
Debt to equity: 0
Current ratio: 4.459371193074311
Quick ratio: 4.459371193074311
Free cash flow (dilution-adjusted): -1046723.7762237763
Buyback yield (%): 0
Retained earnings: -29135256.643356644
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -131.82350008357272
Rule of 40 score: 0
Financial ratios for REVX.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -417532.84671532846
Net income: -417532.84671532846
Capital expenditures: 72992.700729927
Operating cash flow: -244105.83941605838
Net tangible assets: 236936.49635036493
Owner earnings: -490525.54744525545
Return on net tangible assets (%): -207.02827761912243
Buffett classification: The Gruesome
Stock price: 0.1751824817518248
Shares outstanding: 60069829
Book value: 236936.49635036493
P/B ratio: 44.4135111505439
Market cap (USD): 10523181.722627737
Debt to equity: 0
Current ratio: 1.8584864645527794
Quick ratio: 1.8584864645527794
Free cash flow (dilution-adjusted): -502050.3649635036
Buyback yield (%): 0
Retained earnings: -30828786.131386857
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -176.22141508242376
Rule of 40 score: 0
Financial ratios for REVX.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -322648.2014388489
Net income: -863015.8273381295
Capital expenditures: 143884.89208633095
Operating cash flow: -119348.20143884893
Net tangible assets: 2672093.5251798565
Owner earnings: -1006900.7194244604
Return on net tangible assets (%): -37.682091211859316
Buffett classification: The Gruesome
Stock price: 0.2302158273381295
Shares outstanding: 60069829
Book value: 2672093.5251798565
P/B ratio: 5.175352303720037
Market cap (USD): 13829025.381294964
Debt to equity: 0
Current ratio: 7.855030062083978
Quick ratio: 7.855030062083978
Free cash flow (dilution-adjusted): -382666.1870503598
Buyback yield (%): 0
Retained earnings: -29522190.647482015
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.07473460035916
Rule of 40 score: 0
Financial ratios for REVX.V — annual report dated 2025-12-31
Total revenue: 0
Operating income: -2529860.583941606
Net income: -1230027.00729927
Capital expenditures: 66423.35766423357
Operating cash flow: -1937799.9999999998
Net tangible assets: 3665544.525547445
Owner earnings: -1296450.3649635036
Return on net tangible assets (%): -35.36856136728772
Buffett classification: The Gruesome
Stock price: 0.3868613138686131
Shares outstanding: 60069829
Book value: 3665544.525547445
P/B ratio: 6.339765567936253
Market cap (USD): 23238692.970802918
Debt to equity: 0
Current ratio: 1.2583254827915678
Quick ratio: 1.2583254827915678
Free cash flow (dilution-adjusted): -2977818.9781021895
Buyback yield (%): 0
Retained earnings: -30967740.1459854
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -69.01731969996393
Rule of 40 score: 0
Financial ratios for REVX.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -1187319.708029197
Net income: -1445485.4014598539
Capital expenditures: 152554.74452554743
Operating cash flow: -794483.9416058393
Net tangible assets: 3665544.525547445
Owner earnings: -1598040.1459854012
Return on net tangible assets (%): -43.59625520431336
Buffett classification: The Gruesome
Stock price: 0.3868613138686131
Shares outstanding: 60069829
Book value: 3665544.525547445
P/B ratio: 6.339765567936253
Market cap (USD): 23238692.970802918
Debt to equity: 0
Current ratio: 1.2583254827915678
Quick ratio: 1.2583254827915678
Free cash flow (dilution-adjusted): -994950.3649635037
Buyback yield (%): 0
Retained earnings: -30967740.1459854
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -32.39135958529578
Rule of 40 score: 0
Financial ratios for REX.V — annual report dated 2022-04-30
Total revenue: 0
Gross profit: -4153.90625
Operating income: -1612924.21875
Net income: -1816159.375
Capital expenditures: 0
Operating cash flow: -1382302.34375
Depreciation & amortization: 4153.90625
Net tangible assets: 5103187.5
Owner earnings: -1812005.46875
Return on net tangible assets (%): -35.50732691577568
Buffett classification: The Gruesome
Stock price: 0.546875
Shares outstanding: 69819926
Book value: 5103187.5
P/B ratio: 7.482141706776402
Market cap (USD): 38182772.03125
Debt to equity: 0
Current ratio: 48.13002984744639
Quick ratio: 48.13002984744639
Free cash flow (dilution-adjusted): -1614386.71875
Buyback yield (%): 0
Retained earnings: -29635738.28125
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -31.6062111915347
Rule of 40 score: 0
Financial ratios for REX.V — annual report dated 2023-04-30
Total revenue: 0
Gross profit: -2931.6176470588234
Operating income: -1378018.382352941
Net income: -1714061.0294117646
Capital expenditures: 0
Operating cash flow: -1291981.6176470588
Depreciation & amortization: 2931.6176470588234
Net tangible assets: 3326294.117647059
Owner earnings: -1711129.4117647058
Return on net tangible assets (%): -51.44251684439492
Buffett classification: The Gruesome
Stock price: 0.2205882352941176
Shares outstanding: 69819926
Book value: 3326294.117647059
P/B ratio: 4.630214202344951
Market cap (USD): 15401454.26470588
Debt to equity: 0
Current ratio: 15.045443103220935
Quick ratio: 15.045443103220935
Free cash flow (dilution-adjusted): -1291981.6176470588
Buyback yield (%): 0
Retained earnings: -29606520.588235293
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -41.4280377385184
Rule of 40 score: 0
Financial ratios for REX.V — annual report dated 2024-04-30
Total revenue: 0
Gross profit: -2183.211678832117
Operating income: -1201687.591240876
Net income: -1367610.9489051094
Capital expenditures: 0
Operating cash flow: -823434.306569343
Depreciation & amortization: 2183.211678832117
Net tangible assets: 2147851.0948905107
Owner earnings: -1365427.7372262774
Return on net tangible assets (%): -63.57180627998245
Buffett classification: The Gruesome
Stock price: 0.1532846715328467
Shares outstanding: 69819926
Book value: 2147851.0948905107
P/B ratio: 4.982805581270161
Market cap (USD): 10702324.423357664
Debt to equity: 0
Current ratio: 0.12100175746924428
Quick ratio: 0.12100175746924428
Free cash flow (dilution-adjusted): -823434.306569343
Buyback yield (%): 0
Retained earnings: -30758025.547445253
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -55.948365978421485
Rule of 40 score: 0
Financial ratios for REX.V — quarterly report dated 2024-10-31
Total revenue: 0
Gross profit: -403.5971223021583
Operating income: -708882.7338129497
Net income: -647733.8129496403
Capital expenditures: 0
Operating cash flow: -485663.309352518
Depreciation & amortization: 403.5971223021583
Net tangible assets: 2442853.9568345323
Owner earnings: -647330.2158273382
Return on net tangible assets (%): -26.498932284357814
Buffett classification: The Gruesome
Stock price: 0.1366906474820144
Shares outstanding: 69819926
Book value: 2442853.9568345323
P/B ratio: 3.906795518981072
Market cap (USD): 9543730.89208633
Debt to equity: 0
Current ratio: 1.2192797383279261
Quick ratio: 1.2192797383279261
Free cash flow (dilution-adjusted): -485663.309352518
Buyback yield (%): 0
Retained earnings: -31198881.29496403
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -29.018629289305736
Rule of 40 score: 0
Financial ratios for REX.V — quarterly report dated 2025-01-31
Total revenue: 0
Gross profit: -386.89655172413796
Operating income: -546806.2068965518
Net income: -600036.551724138
Capital expenditures: 0
Operating cash flow: -554789.6551724138
Depreciation & amortization: 386.89655172413796
Net tangible assets: 2310919.310344828
Owner earnings: -599649.6551724138
Return on net tangible assets (%): -25.948532797665536
Buffett classification: The Gruesome
Stock price: 0.10344827586206896
Shares outstanding: 69819926
Book value: 2310919.3103448274
P/B ratio: 3.125488169658112
Market cap (USD): 7222750.9655172415
Debt to equity: 0
Current ratio: 1.2919359158771886
Quick ratio: 1.2919359158771886
Free cash flow (dilution-adjusted): -590768.9655172414
Buyback yield (%): 0
Retained earnings: -30507929.655172415
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -23.66184766593859
Rule of 40 score: 0
Financial ratios for REX.V — annual report dated 2025-04-30
Total revenue: 0
Gross profit: -1219.5652173913045
Operating income: -1974674.6376811597
Net income: -2393650.724637681
Capital expenditures: 0
Operating cash flow: -1527591.3043478262
Depreciation & amortization: 1219.5652173913045
Net tangible assets: 1692717.391304348
Owner earnings: -2392431.15942029
Return on net tangible assets (%): -141.33671525503544
Buffett classification: The Gruesome
Stock price: 0.08695652173913043
Shares outstanding: 69819926
Book value: 1692717.3913043481
P/B ratio: 3.586716804726128
Market cap (USD): 6071297.9130434785
Debt to equity: 0
Current ratio: 0.41421994904419723
Quick ratio: 0.41421994904419723
Free cash flow (dilution-adjusted): -1720063.7681159421
Buyback yield (%): 0
Retained earnings: -32928792.02898551
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -116.6570774203215
Rule of 40 score: 0
Financial ratios for REX.V — quarterly report dated 2025-04-30
Total revenue: 0
Gross profit: 0
Operating income: -434264.4927536232
Net income: -873358.695652174
Capital expenditures: 0
Operating cash flow: -221402.89855072467
Depreciation & amortization: 0
Net tangible assets: 1692717.391304348
Owner earnings: -873358.695652174
Return on net tangible assets (%): -51.59506838759391
Buffett classification: The Gruesome
Stock price: 0.08695652173913043
Shares outstanding: 69819926
Book value: 1692717.3913043481
P/B ratio: 3.586716804726128
Market cap (USD): 6071297.9130434785
Debt to equity: 0
Current ratio: 0.41421994904419723
Quick ratio: 0.41421994904419723
Free cash flow (dilution-adjusted): -263107.24637681164
Buyback yield (%): 0
Retained earnings: -32928792.02898551
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.654872749844813
Rule of 40 score: 0
Financial ratios for REX.V — quarterly report dated 2025-10-31
Total revenue: 0
Gross profit: -400.7142857142857
Operating income: -181650.7142857143
Net income: -257830.00000000003
Capital expenditures: 0
Operating cash flow: -156134.2857142857
Depreciation & amortization: 400.7142857142857
Net tangible assets: 1287047.8571428573
Owner earnings: -257429.28571428574
Return on net tangible assets (%): -20.00153174457382
Buffett classification: The Gruesome
Stock price: 0.1285714285714286
Shares outstanding: 69819926
Book value: 1287047.8571428573
P/B ratio: 6.974758225773601
Market cap (USD): 8976847.62857143
Debt to equity: 0
Current ratio: 0.178322946025697
Quick ratio: 0.178322946025697
Free cash flow (dilution-adjusted): -156134.2857142857
Buyback yield (%): 0
Retained earnings: -33311610.000000004
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.113749793963704
Rule of 40 score: 0
Financial ratios for RLTY — annual report dated 2022-12-31
Capital expenditures: 0
Net tangible assets: 260455890
Buffett classification: The Gruesome
Stock price: 9.86
Shares outstanding: 16722406
Book value: 260455890
P/B ratio: 0.6330550756982305
Market cap (USD): 164882923.16
Debt to equity: 0.5643949921808257
Buyback yield (%): 0
Retained earnings: -63896752
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RLTY — annual report dated 2023-12-31
Total revenue: 30894063
Net income: 30431774
Capital expenditures: 0
Operating cash flow: 27858899
Net tangible assets: 268941981
Owner earnings: 30431774
Return on net tangible assets (%): 11.315367681477738
Buffett classification: The Gruesome
Stock price: 11.24
P/E ratio: 6.176433994285052
Shares outstanding: 16722406
Book value: 268941981
P/B ratio: 0.6988862160571353
Market cap (USD): 187959843.44
Debt to equity: 0.5242766468653326
COGS to revenue (%): 0
SG&A to revenue (%): 1.4647280288125262
Free cash flow (dilution-adjusted): 27858899
Buyback yield (%): 0.2356987492072578
Retained earnings: -41617383
Receivables turnover: 5.4915749450736975
Capitalized R&D asset: 0
FCF margin (%): 90.17557515824318
Rule of 40 score: 90.17557515824318
Financial ratios for RLTY — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 267075079
Buffett classification: The Gruesome
Stock price: 12.97
Shares outstanding: 16722406
Book value: 267075079
P/B ratio: 0.8120922649619435
Market cap (USD): 216889605.82000002
Debt to equity: 0.527941433277644
Buyback yield (%): 0
Retained earnings: -29071872
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RLTY — annual report dated 2024-12-31
Total revenue: 20804075
Net income: 20206674
Capital expenditures: 0
Operating cash flow: 20815778
Net tangible assets: 267075079
Owner earnings: 20206674
Return on net tangible assets (%): 7.565915200946173
Buffett classification: The Gruesome
Stock price: 12.97
P/E ratio: 10.733562872346038
Shares outstanding: 16722406
Book value: 267075079
P/B ratio: 0.8120922649619435
Market cap (USD): 216889605.82000002
Debt to equity: 0.527941433277644
COGS to revenue (%): 0
SG&A to revenue (%): 2.773451835758139
Free cash flow (dilution-adjusted): 20815778
Buyback yield (%): 0
Retained earnings: -29071872
Receivables turnover: 6.801829268292683
Capitalized R&D asset: 0
FCF margin (%): 100.05625340227814
Revenue growth (%): -32.65995799904985
Rule of 40 score: 67.3962954032283
Financial ratios for RLTY — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 269133335
Buffett classification: The Gruesome
Stock price: 13.93
Shares outstanding: 16722406
Book value: 269133335
P/B ratio: 0.8655305206989687
Market cap (USD): 232943115.57999998
Debt to equity: 0.5239038857821161
Buyback yield (%): 0
Retained earnings: -27013616
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RPM — annual report dated 2021-05-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 85.33
Shares outstanding: 127626527
Market cap (USD): 10890371548.91
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RPM — annual report dated 2022-05-31
Total revenue: 6707728000
Gross profit: 2433053000
Operating income: 644769000
Net income: 492466000
Capital expenditures: 222403000
Operating cash flow: 178731000
Depreciation & amortization: 153074000
Net tangible assets: 52300000
Owner earnings: 423137000
Return on net tangible assets (%): 809.057361376673
Capex to operating income (%): 34.49343873542308
Buffett classification: The Good
Stock price: 81.85
P/E ratio: 21.212086184528474
Shares outstanding: 127626527
Book value: 1983828000
P/B ratio: 5.265694019315182
Market cap (USD): 10446231234.949999
Debt to equity: 1.4879052014589975
Current ratio: 1.5630809836104598
Quick ratio: 0.9617056667103087
Effective tax rate (%): 18.841988862868924
Interest coverage ratio: 7.332920116458921
COGS to revenue (%): 63.72761388058669
SG&A to revenue (%): 26.66005538686124
Free cash flow (dilution-adjusted): -83786000
Buyback yield (%): 0.6131302147104594
Retained earnings: 2139346000
Inventory turnover: 3.5251620873185123
Receivables turnover: 4.682101195561735
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.74393611320364
FCF margin (%): -1.2490965644402992
Rule of 40 score: -1.2490965644402992
Financial ratios for RPM — annual report dated 2023-05-31
Total revenue: 7256414000
Gross profit: 2748044000
Operating income: 792004000
Net income: 479731000
Capital expenditures: 254435000
Operating cash flow: 577105000
Depreciation & amortization: 154949000
Net tangible assets: 292261000
Owner earnings: 380245000
Return on net tangible assets (%): 130.10459828714744
Capex to operating income (%): 32.12546906328756
Buffett classification: The Good
Stock price: 75.59
P/E ratio: 20.109788977426934
Shares outstanding: 127626527
Book value: 2143000000
P/B ratio: 4.501768164223052
Market cap (USD): 9647289175.93
Debt to equity: 1.3855963602426504
Current ratio: 2.1358772901279246
Quick ratio: 1.3742088984378196
Effective tax rate (%): 26.12499268535315
Interest coverage ratio: 6.654656976011427
COGS to revenue (%): 62.129448512722675
SG&A to revenue (%): 27.09907400542472
Free cash flow (dilution-adjusted): 293997000
Buyback yield (%): 0.6949827954497555
Retained earnings: 2404125000
Inventory turnover: 3.9703970775766715
Receivables turnover: 4.827824941451991
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.968316278925606
FCF margin (%): 4.05154667305366
Revenue growth (%): 8.17990830874478
Rule of 40 score: 12.23145498179844
Financial ratios for RPM — annual report dated 2024-05-31
Total revenue: 7335277000
Gross profit: 3014589000
Operating income: 901004000
Net income: 589442000
Capital expenditures: 213970000
Operating cash flow: 1122305000
Depreciation & amortization: 171251000
Net tangible assets: 689001000
Owner earnings: 546723000
Return on net tangible assets (%): 79.3501025397641
Capex to operating income (%): 23.747952284340577
Buffett classification: The Great
Stock price: 108.12
P/E ratio: 23.410242397453864
Shares outstanding: 127626527
Book value: 2512225000
P/B ratio: 5.492732577392551
Market cap (USD): 13798980099.24
Debt to equity: 0.9586836370149967
Current ratio: 1.9749124185574436
Quick ratio: 1.322509112835456
Effective tax rate (%): 25.182239473393608
Interest coverage ratio: 7.637633615610881
COGS to revenue (%): 58.90286079176015
SG&A to revenue (%): 28.964563983064306
Free cash flow (dilution-adjusted): 882410000
Buyback yield (%): 0.5763179555884715
Retained earnings: 2760639000
Inventory turnover: 4.51735087013116
Receivables turnover: 5.167707801288532
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.59608817846924
FCF margin (%): 12.029675225625427
Revenue growth (%): 1.0868040329562232
Rule of 40 score: 13.11647925858165
Financial ratios for RPM — quarterly report dated 2025-02-28
Total revenue: 1476562000
Gross profit: 567490000
Operating income: 65780000
Net income: 52314000
Capital expenditures: 58192000
Operating cash flow: 91504000
Depreciation & amortization: 47349000
Net tangible assets: 805259000
Owner earnings: 41471000
Return on net tangible assets (%): 5.150020055659111
Capex to operating income (%): 88.46457889936151
Buffett classification: The Gruesome
Stock price: 120.92
P/E ratio: 73.74985493768399
Shares outstanding: 127626527
Book value: 2675782000
P/B ratio: 5.767510075499424
Market cap (USD): 15432599644.84
Debt to equity: 0.8947290922803128
Current ratio: 2.2187692255728164
Quick ratio: 1.3785530869082343
Effective tax rate (%): -27.747796146614245
Interest coverage ratio: 2.8608706997781934
COGS to revenue (%): 61.566801800398494
SG&A to revenue (%): 33.97825489210748
Free cash flow (dilution-adjusted): 25367000
Buyback yield (%): 0.11980483149630547
Retained earnings: 3033505000
Inventory turnover: 0.8701118708699281
Receivables turnover: 1.33615242266432
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2235603634893157
FCF margin (%): 1.7179773013256472
Rule of 40 score: 1.7179773013256472